Aptevo Therapeutics News, Aptevo Therapeutics Quote, APVO Quote

Aptevo Therapeutics (NQ:APVO) Delayed: 4.67 -0.13 (2.71%)

Prev. Close

$4.80

Today 6M 1Y 5Y

Open

$4.87

52 Wk High

$4.33

52 Wk Low

$1.80

Day High

$4.87

Day Low

$4.67

P/E

N/A

EPS

$0.00

Volume

16,578

Friends, Peers and Foes (?): SXTP FMST (more...)

ALERTS | RSS

May 28, 2026 08:03 PM Form 3 Aptevo Therapeutics Inc. For: May 20 Filed by: Janatpour Mary Jo
May 28, 2026 08:05 AM Aptevo Therapeutics names Mary Janatpour as chief scientific officer
May 28, 2026 08:05 AM Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
May 27, 2026 04:06 PM Form 8-K Aptevo Therapeutics Inc. For: May 25
May 27, 2026 08:05 AM Aptevo and Niowave form partnership for cancer drug development
May 27, 2026 08:05 AM Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing
May 13, 2026 04:16 PM Form 10-Q Aptevo Therapeutics Inc. For: Mar 31
May 13, 2026 04:06 PM Form 8-K Aptevo Therapeutics Inc. For: May 13
May 13, 2026 08:07 AM Aptevo names Jeff Lamothe CEO, reports AML trial progress
May 13, 2026 08:07 AM Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

Entities mentioned with APVO

View All Entities